Why Fighting AMR May Be a Hard Sell on Capitol Hill, and more ID in the News
National Journal spoke with Amanda Jezek, IDSA’s senior vice president of public policy and government relations, on why antibiotics are a politically difficult sell on Capitol Hill.
According to Jezek, there is growing understanding among lawmakers about the antibiotic-resistance crisis, but the issue hasn’t had the attention of many large patient-driven advocacy organizations. “Some of that is probably because when patients get antibiotic-resistant infections, they’re acute,” she said. “Either they are lucky, and they get a drug and they are successfully treated and they are able to move on and go about their lives ... or, if there aren’t any antibiotics to treat them, they pass fairly quickly from these acute infections.”
This is just one of the news pieces that IDSA and our member spokespersons contributed to, in addition to others in the pipeline. Follow us on Twitter, LinkedIn and Facebook to see the latest news and opinion pieces featuring IDSA, HIVMA and our members.
- Consumer Reports: What to Do If You Think You Have a Tick-Borne Illness (Dr. Paul Auwaerter, MBA, FIDSA)
- Infectious Disease News: How common is pneumococcal urinary antigen testing? (Dr. Joshua Metlay, Ph.D., FIDSA)
- Infections Disease News: New CAP Guidelines stress de-escalation (Dr. Joshua Metlay, Ph.D, FIDSA)
- Infectious Disease News: Recent laxative use should not preclude testing patients for C. difficile (Dr. Dimitri Drekonja, M.S., FIDSA)
- Infectious Disease News: Shifting from daily to infrequent dosing will advance HIV treatment (Dr. Judith Feinberg, FIDSA)
- Infectious Disease News: Wireless device that transmits OPAT data to doctors wins $10K prize at IDWeek (Dr. Javeed Siddiqui, MPH)
- NPR: News at 6:00 a.m. (Dr. Jeffrey Duchin, FIDSA)